EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus

Anastasia Orekhova, Andrey V Sybachin iD, Veronika Lyamina, Dana Mamiy, Alexander Osmolovskiy iD, Oxana M Drapkina iD

Polymers · 07.06.2026 · 18 (12) · 1421

DOI: 10.3390/polym18121421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polymers, online erschienen am 07.06.2026. Verfasst von Anastasia Orekhova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Lomonosov Moscow State University, Leninskie Gory 1-12, 119991 Moscow, Russia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amphotericin B (AmB) is a broad-spectrum antifungal agent and a long-standing standard of care; however, its clinical use is compromised by poor solubility, off-target tissue distribution and severe dose-limiting toxicity. AmB-loaded poly (D, L-lactide-co-glycolide) nanoparticles (PLGA-AmB-NPs) were developed and characterized with respect to their physicochemical properties, antifungal activity against A. fumigatus biofilms, in vivo efficacy in the Galleria mellonella infection model, and hemolytic toxicity in vitro. Blank PLGA nanoparticles (PLGA-NPs) and PLGA-AmB-NPs exhibited mean diameters of 165 nm (PDI 0.075) and 120 nm (PDI 0.210), respectively, with negative zeta potential values consistent with colloidal stability in aqueous media. PLGA-AmB-NPs showed significantly enhanced activity against 24 h A. fumigatus biofilms compared with free AmB at concentrations of 5 and 10 µg/mL, while unloaded PLGA-NPs were inactive. Infected G. mellonella larvae treated with PLGA-AmB-NPs displayed markedly improved survival over a 5-day period relative to those receiving equivalent doses of free AmB. Furthermore, PLGA-AmB-NPs induced substantially lower hemolysis of human red blood cells than free AmB across all tested concentrations (5–20 µg/mL). PLGA-AmB-NPs represent a promising polymeric platform for the treatment of A. fumigatus infections.

Schlagwörter

Stichwörter der Autor:innen

Aspergillus fumigatusGalleria mellonellaPLGA-NPsamphotericin Bbiofilm

Autor:innen und Institutionen

  • Biology Department, Lomonosov Moscow State University, Leninskie Gory 1-12, 119991 Moscow, Russia.
  • National Medical Research Centre for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
  • Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, Russia.

ORCID-Profile: Andrey V Sybachin, Alexander Osmolovskiy, Oxana M Drapkina

Förderung

  • Russian Science Foundation

Zitieren

APA

Orekhova, A., Sybachin, A. V., Lyamina, V., Mamiy, D., Osmolovskiy, A., & Drapkina, O. M. (2026). Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus. Polymers, 18(12), 1421. https://doi.org/10.3390/polym18121421

Vancouver

Orekhova A, Sybachin AV, Lyamina V, Mamiy D, Osmolovskiy A, Drapkina OM. Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus. Polymers. 2026;18(12):1421. doi:10.3390/polym18121421

BibTeX
@article{Orekhova2026,
  author = {Orekhova, Anastasia and Sybachin, Andrey V and Lyamina, Veronika and Mamiy, Dana and Osmolovskiy, Alexander and Drapkina, Oxana M},
  title = {Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus},
  journal = {Polymers},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1421},
  doi = {10.3390/polym18121421}
}
Kostenlos starten →